141 related articles for article (PubMed ID: 15577585)
1. Effect of radioiodine therapy on thyroid nodule size and function in patients with toxic adenomas.
Erdoğan MF; Küçük NO; Anil C; Aras S; Ozer D; Aras G; Kamel N
Nucl Med Commun; 2004 Nov; 25(11):1083-7. PubMed ID: 15577585
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules.
Nygaard B; Hegedüs L; Nielsen KG; Ulriksen P; Hansen JM
Clin Endocrinol (Oxf); 1999 Feb; 50(2):197-202. PubMed ID: 10396362
[TBL] [Abstract][Full Text] [Related]
3. Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule.
Zakavi SR; Mousavi Z; Davachi B
Nucl Med Commun; 2009 Feb; 30(2):169-75. PubMed ID: 19194214
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount.
Schiavo M; Bagnara MC; Pomposelli E; Altrinetti V; Calamia I; Camerieri L; Giusti M; Pesce G; Reitano C; Bagnasco M; Caputo M
Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):301-7. PubMed ID: 23486350
[TBL] [Abstract][Full Text] [Related]
5. Low failure rate of fixed administered activity of 400 MBq 131I with pre-treatment with carbimazole for thyrotoxicosis: the Gateshead Protocol.
Razvi S; Basu A; McIntyre EA; Wahid ST; Bartholomew PH; Weaver JU;
Nucl Med Commun; 2004 Jul; 25(7):675-82. PubMed ID: 15208494
[TBL] [Abstract][Full Text] [Related]
6. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
[TBL] [Abstract][Full Text] [Related]
7. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
Jarløv AE; Hegedüs L; Kristensen LO; Nygaard B; Hansen JM
Clin Endocrinol (Oxf); 1995 Sep; 43(3):325-9. PubMed ID: 7586602
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm.
Schiavo M; Bagnara MC; Camerieri L; Pomposelli E; Giusti M; Pesce G; Reitano C; Caputo M; Bagnasco M
Endocrine; 2015 Apr; 48(3):902-8. PubMed ID: 25151403
[TBL] [Abstract][Full Text] [Related]
9. [131I-treatment of the autonomous toxic nodule. Assessment of a fixed dose protocol].
Abós MD; Banzo J; Razola P; García F; Prats E
Rev Esp Med Nucl; 1999 Dec; 18(6):431-5. PubMed ID: 10611569
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
[TBL] [Abstract][Full Text] [Related]
11. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules.
Døssing H; Bennedbaek FN; Bonnema SJ; Grupe P; Hegedüs L
Eur J Endocrinol; 2007 Jul; 157(1):95-100. PubMed ID: 17609407
[TBL] [Abstract][Full Text] [Related]
12. Radioiodine therapy of the autonomous thyroid nodule in patients with or without visible extranodular activity.
Clerc J; Dagousset F; Izembart M; Jais JP; Heshmati HM; Alcaïs A; Chevalier A; Léger AF; Barritault L
J Nucl Med; 1995 Feb; 36(2):217-23. PubMed ID: 7830117
[TBL] [Abstract][Full Text] [Related]
13. Delayed radioiodine organification in Plummer's disease.
Intenzo CM; Park CH; Kim SM
Clin Nucl Med; 1995 Mar; 20(3):203-5. PubMed ID: 7750210
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous ethanol injection plus radioiodine versus radioiodine alone in the treatment of large toxic thyroid nodules.
Zingrillo M; Modoni S; Conte M; Frusciante V; Trischitta V
J Nucl Med; 2003 Feb; 44(2):207-10. PubMed ID: 12571210
[TBL] [Abstract][Full Text] [Related]
15. [The efficacy of the radioiodine treatment of toxic thyroid adenoma and multinodular goiter].
Gómez-Arnaiz N; Maravall J; Gómez JM; Gumà A; Andía E; Mora J
Rev Clin Esp; 1999 Oct; 199(10):637-40. PubMed ID: 10589246
[TBL] [Abstract][Full Text] [Related]
16. Thyrotoxicosis due to ectopic retrotracheal adenoma treated with radioiodine.
Salvatori M; Rufini V; Corsello SM; Saletnich I; Rota CA; Barbarino A; Troncone L
J Nucl Biol Med (1991); 1993 Jun; 37(2):69-72. PubMed ID: 8373835
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry study in patients with autonomous thyroid nodule who are candidates for radioiodine therapy.
Reschini E; Matheoud R; Canzi C; Castellani M; Galelli M; Ferrari C; Paracchi A; Gerundini P
J Nucl Med; 1999 Nov; 40(11):1928-34. PubMed ID: 10565791
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of low doses of radioiodine in the treatment of autonomous thyroid nodules: importance of dose/area ratio.
Estour B; Millot L; Vergely N; Clavier A; Dhondt O; Caillot A; Brulport V; Descousus M; Dubois F
Thyroid; 1997 Jun; 7(3):357-61. PubMed ID: 9226203
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine therapy of thyroid autonomy.
Reiners C; Schneider P
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
[TBL] [Abstract][Full Text] [Related]
20. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
Howarth D; Epstein M; Lan L; Tan P; Booker J
Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
